These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
604 related items for PubMed ID: 10871299
1. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. Obach RS. J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299 [Abstract] [Full Text] [Related]
2. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Komoroski BJ, Zhang S, Cai H, Hutzler JM, Frye R, Tracy TS, Strom SC, Lehmann T, Ang CY, Cui YY, Venkataramanan R. Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173 [Abstract] [Full Text] [Related]
4. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line. Tian R, Koyabu N, Morimoto S, Shoyama Y, Ohtani H, Sawada Y. Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377 [Abstract] [Full Text] [Related]
7. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect]. Vacek J, Klejdus B, Kubán V. Ceska Slov Farm; 2007 Apr; 56(2):62-6. PubMed ID: 17619301 [Abstract] [Full Text] [Related]
8. Inhibitory effect of the antidepressant St. John's wort (hypericum perforatum) on rat bladder contractility in vitro. Capasso R, Borrelli F, Capasso F, Mascolo N, Izzo AA. Urology; 2004 Jul; 64(1):168-72. PubMed ID: 15245964 [Abstract] [Full Text] [Related]
9. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG). Dimpfel W, Schober F, Mannel M. Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():30-5. PubMed ID: 9684945 [Abstract] [Full Text] [Related]
12. Quantitative characterization of direct P-glycoprotein inhibition by St John's wort constituents hypericin and hyperforin. Wang EJ, Barecki-Roach M, Johnson WW. J Pharm Pharmacol; 2004 Jan; 56(1):123-8. PubMed ID: 14980009 [Abstract] [Full Text] [Related]
16. In vitro photochemical and phototoxicological characterization of major constituents in St. John's Wort (Hypericum perforatum) extracts. Onoue S, Seto Y, Ochi M, Inoue R, Ito H, Hatano T, Yamada S. Phytochemistry; 2011 Oct; 72(14-15):1814-20. PubMed ID: 21782201 [Abstract] [Full Text] [Related]
17. Effect of St. John's wort on free radical production. Hunt EJ, Lester CE, Lester EA, Tackett RL. Life Sci; 2001 Jun 01; 69(2):181-90. PubMed ID: 11441908 [Abstract] [Full Text] [Related]
18. Metabolism of hyperforin, the active constituent of St. John's wort, in human liver microsomes. Hokkanen J, Tolonen A, Mattila S, Turpeinen M. Eur J Pharm Sci; 2011 Feb 14; 42(3):273-84. PubMed ID: 21168483 [Abstract] [Full Text] [Related]
20. Modulation of P-glycoprotein function by St John's wort extract and its major constituents. Weber CC, Kressmann S, Fricker G, Müller WE. Pharmacopsychiatry; 2004 Nov 14; 37(6):292-8. PubMed ID: 15551196 [Abstract] [Full Text] [Related] Page: [Next] [New Search]